September brought a remarkable wave of progress in cancer care, with 10 FDA decisions covering breast, lung, kidney, bile duct, skin and neuroendocrine cancers, plus advances in brain tumour imaging.
@thecancersurvivorsclub.comExplore
@thecancersurvivorsclub.com@thecancersurvivorsclub.comSix cancer drug approvals in a single month. August brought new FDA-approved treatment options across pancreatic cancer, gastroesophageal cancer, melanoma, multiple myeloma and rare blood cancers.